단계 미표기모집 중
Ocrevus Zunovo for MS: Mixed Methods
연구 개요
Ocrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods study. This study will incorporate clinical data and questionnaire results from MS patients who take Ocrevus Zunovo as well as qualitative interviews with MS patients, family members, and other individuals involved in Ocrevus Zunovo treatment. The purpose of this study is to synthesize implementation strategies that improve patient access to high-efficacy MS therapies in real-world settings.
- 스폰서
- 협력: 로슈
- 적응증
- Multiple Sclerosis
- 중재
- Clinical Questionnaires, Semi-Structured Interviews
- 목표 등록
- 150명
- 시작일
- 2026-06-12
- 완료(예정)
- 2028-12-01
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.